
|Articles|September 7, 2022
Supplements and Featured Publications
- Diagnosis and Trial Options in Sarcoma
- Volume 1
- Issue 1
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Advertisement
Articles in this issue
over 3 years ago
Dr. Blay on Treatment Considerations in Soft Tissue Sarcomasover 3 years ago
Dr. LoRusso on the Benefit of Genetic Sequencing in Sarcomasover 3 years ago
Dr. Martin-Broto on MDM2 and P53 in Soft Tissue Sarcomaover 3 years ago
Dr. LoRusso on the Efficacy of BI 907828 in Solid TumorsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5





































